Biogen
BIIB
BIIB
941 hedge funds and large institutions have $27.8B invested in Biogen in 2024 Q1 according to their latest regulatory filings, with 102 funds opening new positions, 300 increasing their positions, 350 reducing their positions, and 144 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
941
Holders Change
-50
Holders Change %
-5.05%
% of All Funds
13.64%
Holding in Top 10
8
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-20%
% of All Funds
0.12%
New
102
Increased
300
Reduced
350
Closed
144
Calls
$301M
Puts
$303M
Net Calls
-$1.6M
Net Calls Change
-$145M
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$466M |
| 2 |
Ameriprise
Minneapolis,
Minnesota
|
+$129M |
| 3 |
BGC
Beutel, Goodman & Co
Toronto,
Ontario, Canada
|
+$123M |
| 4 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
+$86.3M |
| 5 |
VanEck Associates
New York
|
+$68.2M |
Top Sellers
| 1 |
Morgan Stanley
New York
|
-$314M |
| 2 |
First Trust Advisors
Wheaton,
Illinois
|
-$139M |
| 3 |
CG
Carmignac Gestion
Paris,
France
|
-$93.5M |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
-$82.1M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$82M |
